Timber pharmaceuticals: invitation to the q1 virtual investor summit

Basking ridge, new jersey--(newsfile corp. - february 28, 2022) - timber pharmaceuticals (nyse american: tmbr) today announced that john koconis, chairman and ceo will be attending the q1 virtual investor summit. john koconis, chairman and ceo, will present a corporate overview, including the positive phase 2b study results for tmb-001, its lead asset, and its plans to initiate a phase 3 trial in q2 2022. event:q1 investor summitdate:
TMBR Ratings Summary
TMBR Quant Ranking